Home - Boston Life Sciences Times

LATEST ARTICLES

Pharma

Nexus Pharmaceuticals Receives Patent for EMERPHED® Ready-To-Use Ephedrine Sulfate Injection

Life Sciences Times - August 18, 20210

Venture Capital

EpiEndo Pharmaceuticals Secures EUR 20 Million Series A Funding

Life Sciences Times - August 18, 20210

Biotech

CCC Now Offering Subscriptions to Wiley Content for Emerging Life Science and Biotech Companies

Life Sciences Times - August 18, 20210

People on the Move

EQRx Appoints Richard Buckley as Chief Corporate Affairs Officer

Life Sciences Times - August 18, 20210

Medtech

Always and Thrive Global Launch First Period Tracker and Wellness App That Helps

Life Sciences Times - August 18, 20210

Life Sciences

JLL Expands Life Sciences Project & Development Group with New Hire

Life Sciences Times - August 18, 20210

People on the Move

Mersana Therapeutics Appoints Tushar Misra as Chief Manufacturing Officer

Life Sciences Times - August 17, 20210

Medtech

Lumen Health Tech Reveals 60% of Employed Users Lost Weight During the Pandemic by Measuring Their Metabolism Daily

Life Sciences Times - August 17, 20210

Medtech

Happify Health and Higi Partner to Create an AI-Driven Patient-Engagement Ecosystem to Make Value-Based Healthcare Accessible Worldwide

Life Sciences Times - August 17, 20210

Pharma

Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases

Life Sciences Times - August 17, 20210

1...751752753...831 Page 752 of 831

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

May 1, 2026

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

May 1, 2026

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

May 1, 2026

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

May 1, 2026

Most Popular

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Recent Comments

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Axoft Raises $55 Million to Expand Brain-Computer Interface Trials and Manufacturing

Cerus Signs Four-Year Supply Deal With French Blood Agency for INTERCEPT System

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

POPULAR CATEGORY

ABOUT US

FOLLOW US